報道指華府再列中芯(00981.HK)等80間企業入商務部實體清單
《路透》引述消息人士指,華府將於當地時間周五(18日)將增加約80間企業列入美國商務部的實體清單,其中包括中芯(00981.HK),幾乎所有遭列入企業皆為中國企業,相信相關企業與中國軍方有關。被列入清單企業會有如華為,被限制接觸美國技術。
報道指,目前該實體清單已包含超過275家中國公司和聯屬,包括華為、中興(00763.HK)、海康威視(002415.SZ)等。
上月美國國防部已將中芯列入了所謂的中國軍事公司的黑名單,有效禁止美國投資者從明年初開始購買其股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.